A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma
Completed · Phase 1 · Has a placebo group
Conditions studied: Asthma
In brief
This is a phase one study to evaluate the safety, tolerability, and bioavailability of nebulized AIR645.
Key facts
- Study ID
- NCT00658749
- Run by
- Altair Therapeutics, Inc.
- People needed
- 80
- Starts
- 2008-04-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2009-06-25
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Contract Research Organization (CRO) appointed by Altair Therapeutics--Altair's offices are in: — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.